Shuzo Hamamoto

36PUBLICATIONS
62CO-AUTHORS
Nephrology and urologyOptical technologyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyNanoelectromechanical systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Aug 29, 2026
Intrarenal pressure monitoring in retrograde intrarenal surgery for high-infectious risk populations.

|Jun 11, 2026
Cross-Species Comparison between Mouse Kidney Multi-Omics and Human Genome-Wide Association Studies Highlights Molecular Features Associated with Oxalate Nephropathy.

|May 04, 2026
Durable Progression-Free and Treatment-Free Survival After Nivolumab Plus Ipilimumab Therapy in Metastatic Renal Cell Carcinoma: A Real-World Study with a 5-Year Minimum Follow-Up.

|Mar 26, 2026
Enhanced magnetic hyperthermia using anti-PD-L1 antibody-conjugated magnetoliposomes in a murine subcutaneous bladder cancer model.

Masakazu Gonda, Noriyasu Kawai, Daiki Ishikawa

|Mar 17, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE Study.

Shuzo Hamamoto, Masahiro Nozawa, Suguru Shirotake

|Nov 26, 2025
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE Study.

Tomokazu Sazuka, Katsunori Tatsugami, Suguru Shirotake

Pageof 6

Frequent Collaborators

16 joint publications

Takahiro Yasui

13 joint publications

Taku Naiki

12 joint publications

Kazumi Taguchi

12 joint publications

Atsushi Okada